
Celonic Integrates Merck’s Breez Micro-Bioreactor Platform Into Its Process Development Operations
Celonic Group, a Swiss-based CDMO, is integrating Merck’s Breez™ micro-bioreactor platform into its process development operations. This addition will further enhance Celonic’s capabilities in monoclonal antibody (mAb) development and manufacturing by …